0
From the Archives Journals |

Consider Tanning Motivations and Counsel AccordinglyTANNING, SKIN CANCER, SEASONAL AFFECTIVE DISORDER

Commentary by June K. Robinson, MD
[+] Author Affiliations

Author Affiliations: Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois. Dr Robinson is also editor of the Archives of Dermatology.


JAMA. 2010;303(20):2074-2075. doi:10.1001/jama.2010.674
Text Size: A A A
Published online

EFFECT OF SEASONAL AFFECTIVE DISORDER AND PATHOLOGICAL TANNING MOTIVES ON EFFICACY OF AN APPEARANCE-FOCUSED INTERVENTION TO PREVENT SKIN CANCER

Joel Hillhouse, PhD; Rob Turrisi, PhD; Jerod Stapleton, BS; June Robinson, MD

Objective: To evaluate the robustness of an appearance-focused intervention to prevent skin cancer in individuals reporting seasonal affective disorder (SAD) symptoms and pathological tanning motives.

Design: Randomized, controlled clinical trial.

Setting: College campus.

Participants: Four hundred thirty adult female indoor tanners (200 in the intervention group and 230 control participants).

Intervention: A booklet discussing the history of tanning, current tanning norms, UV radiation's effects on skin, recommendations for indoor tanning use focusing on abstinence and harm reduction recommendations, and information on healthier, appearance-enhancing alternatives to tanning.

Main Outcome Measures: Self-reported attitudes, intentions, and tanning behaviors; pathological tanning motives assessed by a questionnaire developed for this study; and SAD symptoms assessed by the Seasonal Pattern Assessment Questionnaire.

Results: Two of the 4 pathological tanning scales, opiatelike reactions to tanning and dissatisfaction with natural skin tone, were significant moderators demonstrating stronger treatment effects for individuals scoring higher on these scales. Treatment effects were equivalently positive (ie, no significant moderator effects) for all levels of SAD symptoms and all levels of the other 2 pathological tanning motive scales (ie, perceiving tanning as a problem and tolerance to the effects of tanning).

Conclusions: The appearance-focused skin cancer prevention intervention is robust enough to reduce indoor tanning among tanners who exhibit SAD symptoms or pathological tanning motives. Tailored interventions may address individuals' motivations for tanning and their relation to maladaptive behavior, such as dissatisfaction with appearance or the need for relaxation because of anxiety.

UV exposure is an avoidable cause of skin cancer. Despite evidence that UV exposure increases skin cancer risk, intentional suntanning and indoor tanning are prevalent among many young adults and adolescents.1 It is widely accepted that these practices persist largely due to prevailing sociocultural values and the perceived attractiveness of tanned skin.2 Additional motivations for tanning are increased confidence in appearance and the feeling of attractiveness of tanners, socialization with friends, and feeling of relaxation experienced both during and after a tanning session. Furthermore, recent studies point to motivations related to depression, manifested as seasonal affective disorder, and dependence or addiction factors.3 With administration of naltrexone, an opioid antagonist, frequent tanners had withdrawal symptoms, thus supporting a physiological hypothesis.3 The physiological basis of pathological tanning has been supported by studies demonstrating that UV induction of pigment secretes α-melanocyte-stimulating hormone (a cleavage product of the prohormone peptide proopiomelanocortin; POMC), and cleavage of POMC yields β-endorphin, an endogenous opioid that can induce analgesia and euphoria.4

In the May issue of the Archives of Dermatology, Hillhouse et al5 reported the results of a randomized controlled trial of 430 adult female tanners on a college campus. Hillhouse et al5 found that an appearance-focused intervention to prevent skin cancer is robust enough to reduce indoor tanning among individuals who exhibit seasonal affective disorder symptoms or pathological tanning motives. Tailored interventions may address individuals' motivations for tanning and their relationship to maladaptive behavior.

When counseling patients, physicians should consider the patient's perspective of the benefit of tanning. Is the patient tanning to look good for an event such as a prom or wedding? Is the patient a regular tanner who tans year-round and uses tanning to improve his or her mood and relieve stress? The event tanner is at one end of a continuum that extends through spontaneous mood tanners to regular tanners.6 Physicians can elicit this information by taking a history using open-ended questions, such as “How does having a tan make you feel?” This opens a dialog and allows the physician to frame a harm-reduction message that evolves from the patient's responses.

For the event tanner interested in his or her appearance, a suggestion by the physician to consider substituting sunless tanning with a self-applied lotion or a spray-mist tan for UV tanning may be seen by the patient as a worthwhile investment to look good and boost self-confidence. The patient may also be receptive to using sun protection to prevent early aging of the skin; thus, for the appearance-motivated tanner, prevention of wrinkles enables harm-reduction behavior. Regular tanners, who discuss how tanning makes them feel relaxed, may respond to suggestions for other ways to relieve stress such as regular exercise and relaxation methods such as yoga.

Parents should be counseled because they serve as role models and gatekeepers of tanning behavior in their children and adolescents. Because state regulation of access to indoor tanning often requires parental consent for minors, the gatekeeper role of parents is relevant. Parental knowledge about the risks of tanning and attitudes and beliefs toward tanning will shape their decision to allow or disallow their children to tan indoors, underscoring the concomitant need for education efforts targeting parental knowledge of indoor tanning.

Physicians also can advocate for the health of patients at the local community level by encouraging limiting access to indoor tanning for those individuals younger than 18 years, by enforcement in the 32 states that regulate tanning facility use by minors,7 and by enforcement of the federal excise tax on indoor tanning for nonmedical use.8 Tanning packages are offered for a relatively low flat monthly fee so if the unlimited monthly use of indoor tanning is abolished, taxation of single sessions may become an effective deterrent to indoor tanning. The 10% excise tax goes into effect on July 1, 2010, and is intended as a measure to promote melanoma prevention.9 While the intention of the law is to have the increased cost serve as a deterrent to indoor tanning, the owners of tanning establishments have stated that they will pay the tax rather than pass the tax onto the customer. The law does allow the tax to be paid by the person who provides the service in the event that the tax is not collected at the time the service is provided.

The federal excise tax uses a strategy that was successful with tobacco control. Tobacco products, like indoor tanning, are associated with serious health risks, place emphasis on social appeal in advertising, and are used by adolescents. Youth, perhaps because of their lower incomes, are particularly cost-sensitive, and tobacco taxation is the single most effective intervention for reducing demand.10 Taxation only becomes a deterrent to indoor tanning if the cost is borne by the client and the taxation raises the price until the price becomes a barrier. Physicians, as respected members of the community, can work with the chamber of commerce and local government to prohibit purchase of unlimited tanning sessions at low monthly fees. The federal tax on tanning may help reduce the health risks of contracting skin cancer and the future costs of treating skin cancer.

In the United States, the indoor tanning industry is still increasing rapidly, generating more than $5 billion in revenues and attracting more than 30 million patrons per year, with more than 1 million individuals on average using tanning beds each day.11 It will take a continuing concerted effort by physicians to help patients avoid the adverse effects of chronic UV exposure.

AUTHOR INFORMATION

Corresponding Author: June K. Robinson, MD, Northwestern University Feinberg School of Medicine, 132 E Delaware Place, #5806, Chicago, IL 60611 (june-robinson@northwestern.edu).

Financial Disclosures: None reported.

REFERENCES

Cokkinides V, Weinstock M, Glanz K, Albano J, Ward E, Thun M. Trends in sunburns, sun protection practices, and attitudes toward sun exposure protection and tanning among US adolescents, 1998-2004.  Pediatrics. 2006;118(3):853-864
PubMedCrossRef
Hillhouse J, Stapleton J, Turrisi R. Association of frequent indoor UV tanning with seasonal affective disorder.  Arch Dermatol. 2005;141(11):1465
PubMedCrossRef
Kaur M, Liguori A, Lang W, Rapp SR, Fleischer AB Jr, Feldman SR. Induction of withdrawal-like symptoms in a small randomized, controlled trial of opioid blockade in frequent tanners.  J Am Acad Dermatol. 2006;54(4):709-711
PubMedCrossRef
van Steensel M. UV addiction: a form of opiate dependence.  Arch Dermatol. 2009;145211
CrossRef
Hillhouse J, Turrisi R, Stapleton J, Robinson J. Effect of seasonal affective disorder and pathological tanning motives on efficacy of an appearance-focused intervention to prevent skin cancer.  Arch Dermatol. 2010;146(5):485-491
CrossRef
Hillhouse J, Turrisi R, Shields AL. Patterns of indoor tanning use: implications for clinical interventions.  Arch Dermatol. 2007;143(12):1530-1535
PubMedCrossRef
National Conference of Stage Legislatures.  Tanning restrictions for minors, a state-by-state comparison. http://www.ncsl.org/default.aspx?tabid=14394. Accessibility verified April 26, 2010
Kwon HT, Mayer JA, Walker KK, Yu H, Lewis EC, Belch GE. Promotion of frequent tanning sessions by indoor tanning facilities: two studies.  J Am Acad Dermatol. 2002;46(5):700-705
PubMedCrossRef
US House of Representatives.  Patient Protection and Affordable Care Act, Pub L No. 111-148 (2009)
Cokkinides V, Bandi P, McMahon C, Jemal A, Glynn T, Ward E. Tobacco control in the United States–recent progress and opportunities.  CA Cancer J Clin. 2009;59(6):352-365
PubMedCrossRef
Bizzozero J. The state of the industry report 2008. http://www.lookingfit.com/articles/state-of-the-industry-2008-fact-book-2009.html. Accessed March 26, 2010

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Cokkinides V, Weinstock M, Glanz K, Albano J, Ward E, Thun M. Trends in sunburns, sun protection practices, and attitudes toward sun exposure protection and tanning among US adolescents, 1998-2004.  Pediatrics. 2006;118(3):853-864
PubMedCrossRef
Hillhouse J, Stapleton J, Turrisi R. Association of frequent indoor UV tanning with seasonal affective disorder.  Arch Dermatol. 2005;141(11):1465
PubMedCrossRef
Kaur M, Liguori A, Lang W, Rapp SR, Fleischer AB Jr, Feldman SR. Induction of withdrawal-like symptoms in a small randomized, controlled trial of opioid blockade in frequent tanners.  J Am Acad Dermatol. 2006;54(4):709-711
PubMedCrossRef
van Steensel M. UV addiction: a form of opiate dependence.  Arch Dermatol. 2009;145211
CrossRef
Hillhouse J, Turrisi R, Stapleton J, Robinson J. Effect of seasonal affective disorder and pathological tanning motives on efficacy of an appearance-focused intervention to prevent skin cancer.  Arch Dermatol. 2010;146(5):485-491
CrossRef
Hillhouse J, Turrisi R, Shields AL. Patterns of indoor tanning use: implications for clinical interventions.  Arch Dermatol. 2007;143(12):1530-1535
PubMedCrossRef
National Conference of Stage Legislatures.  Tanning restrictions for minors, a state-by-state comparison. http://www.ncsl.org/default.aspx?tabid=14394. Accessibility verified April 26, 2010
Kwon HT, Mayer JA, Walker KK, Yu H, Lewis EC, Belch GE. Promotion of frequent tanning sessions by indoor tanning facilities: two studies.  J Am Acad Dermatol. 2002;46(5):700-705
PubMedCrossRef
US House of Representatives.  Patient Protection and Affordable Care Act, Pub L No. 111-148 (2009)
Cokkinides V, Bandi P, McMahon C, Jemal A, Glynn T, Ward E. Tobacco control in the United States–recent progress and opportunities.  CA Cancer J Clin. 2009;59(6):352-365
PubMedCrossRef
Bizzozero J. The state of the industry report 2008. http://www.lookingfit.com/articles/state-of-the-industry-2008-fact-book-2009.html. Accessed March 26, 2010
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.